Microfinance trials on trial

Olga Biosca, Neil Craig, Cam Donaldson and Neil McHugh

Oxford Development Studies, 2024, vol. 52, issue 2, 195-204

Abstract: Microfinance has attracted great attention, stimulated, initially, by its association with the award of the Nobel Prize for Peace, based on its transformative potential in addressing poverty. However, work based on randomised trials associated with the award of the Memorial Prize in Economic Sciences, put the brakes on. As health economists, and given their promotion as a ‘gold standard’ method borrowed from medicine, we take a particular perspective on the microfinance trials. We question whether full account had been taken of methodological developments in the health arena that were in place before the microfinance trials were embarked upon. This may help explain the outcomes of research, subsequent to the trials, casting doubt on their initial results, but also aid calls for even greater attention to be paid to developments in health evaluations – many drawing from social science more broadly – to better explain what works for whom in which circumstances.

Date: 2024
References: Add references at CitEc
Citations:

Downloads: (external link)
http://hdl.handle.net/10.1080/13600818.2024.2379401 (text/html)
Access to full text is restricted to subscribers.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:taf:oxdevs:v:52:y:2024:i:2:p:195-204

Ordering information: This journal article can be ordered from
http://www.tandfonline.com/pricing/journal/CODS20

DOI: 10.1080/13600818.2024.2379401

Access Statistics for this article

Oxford Development Studies is currently edited by Jo Boyce and Frances Stewart

More articles in Oxford Development Studies from Taylor & Francis Journals
Bibliographic data for series maintained by Chris Longhurst ().